Adoptive T-Cell Therapy for Epstein-Barr Virus-Related Lymphomas.
作者信息
Heslop Helen E, Sharma Sandhya, Rooney Cliona M
机构信息
Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital, Houston, TX.
出版信息
J Clin Oncol. 2021 Feb 10;39(5):514-524. doi: 10.1200/JCO.20.01709. Epub 2021 Jan 12.
Abstract
摘要
相似文献
1
Adoptive T-Cell Therapy for Epstein-Barr Virus-Related Lymphomas.采用过继性T细胞疗法治疗爱泼斯坦-巴尔病毒相关淋巴瘤。
J Clin Oncol. 2021 Feb 10;39(5):514-524. doi: 10.1200/JCO.20.01709. Epub 2021 Jan 12.
2
EBV-related lymphomas: new approaches to treatment.EBV 相关淋巴瘤：新的治疗方法。
Curr Treat Options Oncol. 2013 Jun;14(2):224-36. doi: 10.1007/s11864-013-0231-y.
3
Epstein-Barr virus-specific cytokine-induced killer cells for treatment of Epstein-Barr virus-related malignant lymphoma.细胞因子诱导的杀伤细胞治疗 EBV 相关恶性淋巴瘤。
Cytotherapy. 2018 Jun;20(6):839-850. doi: 10.1016/j.jcyt.2018.04.005. Epub 2018 May 10.
4
Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein-Barr virus-associated lymphoma.用于爱泼斯坦-巴尔病毒相关淋巴瘤患者的、针对潜伏膜蛋白（LMP）-1和LMP2的药品生产质量管理规范级细胞毒性T淋巴细胞。
Cytotherapy. 2011 May;13(5):518-22. doi: 10.3109/14653249.2011.561983. Epub 2011 Mar 1.
5
Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomas.用于预防和治疗EB病毒相关移植后淋巴瘤的EB病毒特异性细胞毒性T淋巴细胞
Recent Results Cancer Res. 2002;159:123-33. doi: 10.1007/978-3-642-56352-2_15.
6
EBV-associated lymphomas in adults.成人 EBV 相关淋巴瘤。
Best Pract Res Clin Haematol. 2012 Mar;25(1):75-89. doi: 10.1016/j.beha.2012.01.005. Epub 2012 Feb 5.
7
Immunotherapy with virus-specific cytotoxic T lymphocytes after organ transplantation.器官移植后采用病毒特异性细胞毒性T淋巴细胞进行免疫治疗。
Pediatr Transplant. 2006 Mar;10(2):142-4. doi: 10.1111/j.1399-3046.2006.00493.x.
8
'Off-the-shelf' allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies.异体抗原特异性过继性 T 细胞治疗用于治疗多种 EBV 相关恶性肿瘤。
J Immunother Cancer. 2021 Feb;9(2). doi: 10.1136/jitc-2020-001608.
9
Reduced-intensity SCT for chronic active EBV infection: excellent outcomes should trigger future investigations on how EBV-positive recipient cells are eradicated.降低强度的干细胞移植治疗慢性活动性EB病毒感染：优异的疗效应引发对如何清除EB病毒阳性受者细胞的进一步研究。
Bone Marrow Transplant. 2011 Jan;46(1):18-9. doi: 10.1038/bmt.2010.258. Epub 2010 Oct 18.
10
Safety of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for patients with refractory EBV-related lymphoma.异基因爱泼斯坦-巴尔病毒（EBV）特异性细胞毒性T淋巴细胞用于难治性EBV相关淋巴瘤患者的安全性
Br J Haematol. 2002 Sep;118(3):799-808. doi: 10.1046/j.1365-2141.2002.03683.x.
引用本文的文献
1
IRF4 Mediates Immune Evasion to Facilitate EBV Transformation.IRF4介导免疫逃逸以促进EB病毒转化。
Viruses. 2025 Jun 24;17(7):885. doi: 10.3390/v17070885.
2
Targeting intracellular LMP2 with costimulatory signal-armed antibody-like TCR T cells.用共刺激信号增强的抗体样TCR T细胞靶向细胞内LMP2。
JCI Insight. 2025 May 22;10(10). doi: 10.1172/jci.insight.178572.
3
Differential antibody response to EBV proteome following EBVST immunotherapy in EBV-associated lymphomas.EBV相关淋巴瘤患者接受EBVST免疫治疗后对EBV蛋白质组的差异性抗体反应。
Blood Adv. 2025 Apr 8;9(7):1658-1669. doi: 10.1182/bloodadvances.2024014937.
4
How Epstein Barr Virus Causes Lymphomas.爱泼斯坦-巴尔病毒如何导致淋巴瘤。
Viruses. 2024 Nov 6;16(11):1744. doi: 10.3390/v16111744.
5
Dihydrotestosterone Enhances MICA-Mediated Immune Responses to Epstein-Barr Virus-Associated Gastric Carcinoma.双氢睾酮增强MICA介导的对爱泼斯坦-巴尔病毒相关胃癌的免疫反应。
Cancers (Basel). 2024 Sep 21;16(18):3219. doi: 10.3390/cancers16183219.
6
Post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation: a case report, meta-analysis, and systematic review.异基因造血干细胞移植后移植后淋巴组织增生性疾病：病例报告、荟萃分析和系统评价。
Diagn Pathol. 2024 Sep 7;19(1):122. doi: 10.1186/s13000-024-01544-8.
7
Stem cell memory EBV-specific T cells control EBV tumor growth and persist in vivo.干细胞记忆 EBV 特异性 T 细胞控制 EBV 肿瘤生长并在体内持续存在。
Sci Adv. 2024 Aug 23;10(34):eado2048. doi: 10.1126/sciadv.ado2048.
8
Establishment of a protocol for rapidly expanding Epstein-Barr-virus-specific cytotoxic T cells with enhanced cytotoxicity.建立一种用于快速扩增具有增强细胞毒性的爱泼斯坦-巴尔病毒特异性细胞毒性T细胞的方案。
BMC Cancer. 2024 Aug 8;24(1):980. doi: 10.1186/s12885-024-12707-7.
9
Combined treatment with allogeneic Epstein-Barr- and human polyomavirus 1 specific T-cells in progressive multifocal leukoencephalopathy and EBV infection: a case report.异基因爱泼斯坦-巴尔病毒和人多瘤病毒1特异性T细胞联合治疗进行性多灶性白质脑病和EB病毒感染：一例报告
Ther Adv Neurol Disord. 2024 May 28;17:17562864241253917. doi: 10.1177/17562864241253917. eCollection 2024.
10
Cotargeting EBV lytic as well as latent cycle antigens increases T-cell potency against lymphoma.同时针对 EBV 裂解期和潜伏期抗原可增强 T 细胞对淋巴瘤的杀伤力。
Blood Adv. 2024 Jul 9;8(13):3360-3371. doi: 10.1182/bloodadvances.2023012183.
本文引用的文献
1
Virus-specific T cells for malignancies - then, now and where to?针对恶性肿瘤的病毒特异性T细胞——过去、现在与未来何去何从？
Curr Stem Cell Rep. 2020 Jun;6(2):17-29. doi: 10.1007/s40778-020-00170-6. Epub 2020 May 7.
2
Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to virus-directed immunotherapy.表观遗传重编程使免疫沉默的 EBV+淋巴瘤对病毒导向的免疫治疗敏感。
Blood. 2020 May 21;135(21):1870-1881. doi: 10.1182/blood.2019004126.
3
Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes.难治性爱泼斯坦-巴尔病毒（EBV）相关移植后淋巴细胞增生性疾病：通过联合使用维布妥昔单抗和同种异体EBV特异性T淋巴细胞实现治愈
Front Med (Lausanne). 2019 Dec 18;6:295. doi: 10.3389/fmed.2019.00295. eCollection 2019.
4
Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation.现成的EBV特异性T细胞免疫疗法用于移植后利妥昔单抗难治性EBV相关淋巴瘤。
J Clin Invest. 2020 Feb 3;130(2):733-747. doi: 10.1172/JCI121127.
5
T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor-Expressing T Cells.T 细胞受体刺激增强表达嵌合抗原受体的 CD19 T 细胞的扩增和功能。
Clin Cancer Res. 2019 Dec 15;25(24):7340-7350. doi: 10.1158/1078-0432.CCR-18-3199. Epub 2019 Sep 26.
6
T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapy.T 细胞受体测序显示抗病毒免疫治疗后病毒特异性 T 细胞持续存在。
Br J Haematol. 2019 Oct;187(2):206-218. doi: 10.1111/bjh.16053. Epub 2019 Jun 20.
7
Long-term follow up after third-party viral-specific cytotoxic lymphocytes for immunosuppression- and Epstein-Barr virus-associated lymphoproliferative disease.第三方病毒特异性细胞毒性淋巴细胞治疗免疫抑制和爱泼斯坦-巴尔病毒相关淋巴增殖性疾病后的长期随访
Haematologica. 2019 Aug;104(8):e356-e359. doi: 10.3324/haematol.2018.207548. Epub 2019 Feb 21.
8
Epstein-Barr Virus (EBV)-derived BARF1 encodes CD4- and CD8-restricted epitopes as targets for T-cell immunotherapy.EB 病毒（EBV）衍生的 BARF1 编码 CD4 和 CD8 限制性表位，作为 T 细胞免疫治疗的靶点。
Cytotherapy. 2019 Feb;21(2):212-223. doi: 10.1016/j.jcyt.2018.08.001. Epub 2018 Nov 2.
9
EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation.异基因骨髓移植后，EBV/LMP 特异性 T 细胞可维持 T 和 B 细胞 EBV 淋巴瘤的缓解。
Blood. 2018 Nov 29;132(22):2351-2361. doi: 10.1182/blood-2018-07-863654. Epub 2018 Sep 27.
10
Establishment and Operation of a Third-Party Virus-Specific T Cell Bank within an Allogeneic Stem Cell Transplant Program.在异基因干细胞移植项目中建立和运营第三方病毒特异性 T 细胞库。
Biol Blood Marrow Transplant. 2018 Dec;24(12):2433-2442. doi: 10.1016/j.bbmt.2018.08.024. Epub 2018 Aug 29.
Zotero 插件